Roberto Pecoits-Filho , Ikechi G. Okpechi , Jo-Ann Donner , David C.H. Harris , Harith M. Aljubori , Aminu K. Bello , Ezequiel Bellorin-Font , Fergus J. Caskey , Allan Collins , Alfonso M. Cueto-Manzano , John Feehally , Bak Leong Goh , Kitty J. Jager , Masaomi Nangaku , Muhibur Rahman , Manisha Sahay , Abdulkarim Saleh , Laura Sola , Rumeyza Turan Kazancioglu , Rachael C. Walker , David W. Johnson
{"title":"捕获和监测未治疗和治疗的终末期肾脏疾病、肾脏替代治疗方式和结果的全球差异","authors":"Roberto Pecoits-Filho , Ikechi G. Okpechi , Jo-Ann Donner , David C.H. Harris , Harith M. Aljubori , Aminu K. Bello , Ezequiel Bellorin-Font , Fergus J. Caskey , Allan Collins , Alfonso M. Cueto-Manzano , John Feehally , Bak Leong Goh , Kitty J. Jager , Masaomi Nangaku , Muhibur Rahman , Manisha Sahay , Abdulkarim Saleh , Laura Sola , Rumeyza Turan Kazancioglu , Rachael C. Walker , David W. Johnson","doi":"10.1016/j.kisu.2019.11.001","DOIUrl":null,"url":null,"abstract":"<div><p><span>A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust </span>health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":null,"pages":null},"PeriodicalIF":19.3000,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2019.11.001","citationCount":"37","resultStr":"{\"title\":\"Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes\",\"authors\":\"Roberto Pecoits-Filho , Ikechi G. Okpechi , Jo-Ann Donner , David C.H. Harris , Harith M. Aljubori , Aminu K. Bello , Ezequiel Bellorin-Font , Fergus J. Caskey , Allan Collins , Alfonso M. Cueto-Manzano , John Feehally , Bak Leong Goh , Kitty J. Jager , Masaomi Nangaku , Muhibur Rahman , Manisha Sahay , Abdulkarim Saleh , Laura Sola , Rumeyza Turan Kazancioglu , Rachael C. Walker , David W. Johnson\",\"doi\":\"10.1016/j.kisu.2019.11.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust </span>health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.</p></div>\",\"PeriodicalId\":48895,\"journal\":{\"name\":\"Kidney International Supplements\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":19.3000,\"publicationDate\":\"2020-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.kisu.2019.11.001\",\"citationCount\":\"37\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney International Supplements\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2157171619300152\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney International Supplements","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2157171619300152","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes
A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.
期刊介绍:
Kidney International Supplements is published on behalf of the International Society of Nephrology (ISN) and comes complimentary as part of a subscription to Kidney International. Kidney International Supplements is a peer-reviewed journal whose focus is sponsored, topical content of interest to the nephrology community.